#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heritable pulmonary arterial hypertension Ependymoma Malignant fibrous histiocytoma Medullary thyroid cancer Malignant neoplasm of choroid Renal cancer metastatic B-cell small lymphocytic lymphoma recurrent Congenital ectodermal dysplasia Erythema Burkitt's lymphoma Congenital growth hormone deficiency Vascular malformation Squamous cell carcinoma of head and neck Marginal zone lymphoma recurrent Skin angiosarcoma More trials…

    Learn about Rare Diseases

    Retinoblastoma – Treatment Acute respiratory distress syndrome – Treatment Cystic fibrosis lung – Trials in Disease Breast angiosarcoma – Basic Information Breast angiosarcoma – Trials in Disease Methylmalonic acidaemia – Diagnostics Ornithine transcarbamoylase deficiency – Life with Disease Wolfram syndrome – Basic Information Lymphangioma – Basic Information Glycogen storage disease type I – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Resatorvid ILOPROST S227928 Inaxaplin Cetrimide Cefazolin Sodium L-Acetylleucine Vilobelimab Sarilumab Mifepristone GSK5784283 OSIMERTINIB MESYLATE MAPLIRPACEPT Granisetron Pp1815 Human Albumin Solution Afm24 ALE1 Vo659 Norepinephrine More therapies…

    Learn about Your Condition

    Endocarditis bacterial Peritonitis Vulvovaginal pain Biliary adenoma Angiosarcoma Gastrointestinal melanoma Pertussis Combined immunodeficiency Infection Acute cardiac event Dent's disease Radiation skin injury Oesophageal carcinoma Huntington's disease Coma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Università degli studi Gabriele D’Annunzio Chieti-Pescara…

Università degli studi Gabriele D’Annunzio Chieti-Pescara Centro di Studi e tecnologie avanzate

Via Luigi Polacchi 11, Chieti, 66100, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    • D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
    Czechia France Germany Italy The Netherlands Poland +1
  • Study on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Dapagliflozin
    • Hydrochlorothiazide
    • Losartan Potassium
    Italy
  • Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +15
  • Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Adalimumab
    • Baricitinib
    • Etanercept
    Austria Belgium Czechia Denmark France Germany +9
  • Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Choroidal neovascularisation
    Investigated Drugs:
    • Faricimab
    • Ranibizumab
    France Germany Italy Poland Spain
  • Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Fenebrutinib
    • Teriflunomide
    Austria Bulgaria Denmark France Greece Italy +1
  • A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Bulgaria Denmark France Germany Ireland Italy +3
  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Dapagliflozin
    • Metformin
    Bulgaria Croatia Czechia Denmark Finland Germany +9
  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12
Previous Page
1 2 3 4 5 6 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!